Last: | $7.54 |
---|---|
Change Percent: | -1.74% |
Open: | $7.62 |
Close: | $7.54 |
High: | $7.7075 |
Low: | $7 |
Volume: | 1,712,046 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.54 | $7.62 | $7.54 | $7.7075 | $7 | 1,712,046 | 07-03-2024 |
$7.49 | $7.28 | $7.49 | $8.2875 | $7.24 | 4,673,917 | 07-02-2024 |
$7.06 | $6.83 | $7.06 | $7.195 | $6.69 | 1,954,780 | 07-01-2024 |
$6.82 | $7.09 | $6.82 | $7.35 | $6.79 | 10,588,276 | 06-28-2024 |
$6.98 | $6.51 | $6.98 | $7.13 | $6.3 | 2,060,458 | 06-27-2024 |
$6.56 | $6.83 | $6.56 | $7.1799 | $6.285 | 2,326,414 | 06-26-2024 |
$6.89 | $6.8 | $6.89 | $7.005 | $6.55 | 1,575,589 | 06-25-2024 |
$6.77 | $6.48 | $6.77 | $6.97 | $6.28 | 1,421,634 | 06-24-2024 |
$6.52 | $6.54 | $6.52 | $6.92 | $6.36 | 3,515,431 | 06-21-2024 |
$6.47 | $6.23 | $6.47 | $6.73 | $6.11 | 2,438,276 | 06-20-2024 |
$6.06 | $5.92 | $6.06 | $6.24 | $5.86 | 1,235,181 | 06-19-2024 |
$6.06 | $5.92 | $6.06 | $6.24 | $5.86 | 1,235,181 | 06-18-2024 |
$6.01 | $6 | $6.01 | $6.07 | $5.8405 | 1,041,417 | 06-17-2024 |
$6.17 | $5.95 | $6.17 | $6.2756 | $5.75 | 1,683,070 | 06-14-2024 |
$6.04 | $6.35 | $6.04 | $6.48 | $6 | 1,101,540 | 06-13-2024 |
$6.32 | $6.77 | $6.32 | $6.94 | $6.29 | 1,968,183 | 06-12-2024 |
$6.48 | $6.26 | $6.48 | $6.58 | $6.25 | 1,379,229 | 06-11-2024 |
$6.39 | $6.04 | $6.39 | $6.4099 | $5.9619 | 1,383,002 | 06-10-2024 |
$6.19 | $6.1 | $6.19 | $6.4488 | $5.91 | 1,626,984 | 06-07-2024 |
$6.26 | $6.67 | $6.26 | $7.18 | $5.93 | 5,216,357 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human S...